It’s only fair to share… Davelizomib Molecular Weight 481.25 Formula C21H26BF2N3O7 CAS No. 2409841-51-4 {(4S)-2-[(1R)-1-{2-[(2S)-1-(2,4-difluorophenyl)azetidine-2- carboxamido]acetamido}-3-methylbutyl]-5-oxo-1,3,2- dioxaborolan-4-yl}acetic acid proteasome inhibitor, antineoplastic 2-[(4S)-2-[(1R)-1-[[2-[[(2S)-1-(2,4-difluorophenyl)azetidine-2-carbonyl]amino]acetyl]amino]-3-methylbutyl]-5-oxo-1,3,2-dioxaborolan-4-yl]acetic acid T3LN9U6BRF Davelizomib is proteasome inhibitor with antineoplastic effect. DAVELIZOMIB is a small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication. Multiple myeloma (MM) is a malignant proliferative …